Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$88,424,894
+$28,201,112 QoQ
Shares Held
1,084,835
+12.9% QoQ
Ownership
0.768%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ARWR ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,424,894 | 1,084,835 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $60,223,782 | 960,507 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $97,991,968 | 1,476,005 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $58,725,222 | 1,702,674 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $26,943,200 | 1,705,266 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $23,550,346 | 1,848,536 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $28,884,542 | 1,536,412 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $31,103,683 | 1,605,766 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $47,179,070 | 1,815,278 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $32,485,793 | 1,135,867 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $27,523,226 | 899,452 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $19,760,891 | 735,426 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $19,313,950 | 541,614 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,110,403 | 634,268 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,488,941 | 431,187 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,125,335 | 427,393 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,977,164 | 538,971 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $13,982,797 | 304,040 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $21,737,445 | 327,865 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,690,535 | 283,366 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,676,166 | 189,280 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $25,012,727 | 377,209 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $41,164,030 | 536,479 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $22,127,800 | 513,883 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,088,103 | 140,961 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,082,045 | 419,953 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||